治疗机构：去分化脂肪肉瘤生存的一个重要预后因素。
Treatment Facility: An Important Prognostic Factor for Dedifferentiated Liposarcoma Survival.
作者信息
Gootee Jonathan Michael, Curtin Christina E, Aurit Sarah J, Randhawa Saboor E, Kang Bianca Y, Silberstein Peter T
机构信息
, and are Medical Students; is a Statistician in the Division of Clinical Research and Evaluative Sciences; is a Second Year Resident in the Department of Internal Medicine; and is Chief of Hematology/Oncology and Associate Professor in the Department of Internal Medicine, all at Creighton University School of Medicine in Omaha, Nebraska. Peter Silberstein also is Chief of Oncology at VA Nebraska-Western Iowa Healthcare System in Omaha.
出版信息
Fed Pract. 2019 Aug;36(Suppl 5):S34-S41.
Abstract
A National Cancer Database study of on survival outcomes for patients with dedifferentiated liposarcomas found that insurance status, median household income, and treatment facility were associated with differences in median survival and 5- and 10-year survival probabilities.
摘要
一项针对去分化脂肪肉瘤患者生存结果的国家癌症数据库研究发现，保险状况、家庭收入中位数和治疗机构与中位生存期以及5年和10年生存概率的差异有关。
相似文献
1
Treatment Facility: An Important Prognostic Factor for Dedifferentiated Liposarcoma Survival.
Fed Pract. 2019 Aug;36(Suppl 5):S34-S41.
2
Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation.
Am J Surg Pathol. 1997 Mar;21(3):271-81. doi: 10.1097/00000478-199703000-00002.
3
Primary anatomical site, adjuvant therapy, and other prognostic variables for dedifferentiated liposarcoma.
J Cancer Res Clin Oncol. 2019 Jan;145(1):181-192. doi: 10.1007/s00432-018-2777-3. Epub 2018 Oct 25.
4
Correlation of histological grade of dedifferentiation with clinical outcome in 55 patients with dedifferentiated liposarcomas.
Hum Pathol. 2017 Aug;66:86-92. doi: 10.1016/j.humpath.2017.02.015. Epub 2017 Mar 12.
5
Distinct chromosomal imbalances in pleomorphic and in high-grade dedifferentiated liposarcomas.
Int J Cancer. 2002 May 1;99(1):68-73. doi: 10.1002/ijc.10287.
6
Dedifferentiated liposarcoma. Clinicopathologic analysis of 32 cases suggesting a better prognostic subgroup among pleomorphic sarcomas.
Am J Surg Pathol. 1994 Dec;18(12):1213-23. doi: 10.1097/00000478-199412000-00004.
7
[An exceptional association between retroperitoneal dedifferentiated liposarcoma and well differentiated pericolonic liposarcoma: about a case].
Pan Afr Med J. 2016 Dec 21;25:254. doi: 10.11604/pamj.2016.25.254.10398. eCollection 2016.
8
Primary mediastinal liposarcoma: clinicopathologic analysis of 24 cases.
Am J Surg Pathol. 2007 Dec;31(12):1868-74. doi: 10.1097/PAS.0b013e318093f925.
9
Liposarcomas of the mediastinum and thorax: a clinicopathologic and molecular cytogenetic study of 24 cases, emphasizing unusual and diverse histologic features.
Am J Surg Pathol. 2012 Sep;36(9):1395-403. doi: 10.1097/PAS.0b013e3182562bc1.
10
Heterologous elements in the dedifferentiated component of dedifferentiated liposarcoma.
Am J Surg Pathol. 1994 Nov;18(11):1150-7. doi: 10.1097/00000478-199411000-00009.
引用本文的文献
1
Histomorphological and molecular characteristics of liposarcoma (Review).
Oncol Lett. 2025 Jul 21;30(4):454. doi: 10.3892/ol.2025.15200. eCollection 2025 Oct.
2
Molecular docking and biological evaluation of a novel IWS1 inhibitor for the treatment of human retroperitoneal liposarcoma.
Sci Rep. 2025 Jul 2;15(1):22965. doi: 10.1038/s41598-025-07215-y.
3
Combination of immune checkpoint inhibitors and anthracyclines as a potential first-line regimen for dedifferentiated liposarcoma: systematic review and meta-analysis.
Cancer Immunol Immunother. 2025 Apr 21;74(6):179. doi: 10.1007/s00262-025-04007-1.
4
Case Report: an extremely rare case of giant dedifferentiated retroperitoneal liposarcoma.
Front Oncol. 2025 Mar 17;15:1489833. doi: 10.3389/fonc.2025.1489833. eCollection 2025.
5
Deciphering the roles of non-coding RNAs in liposarcoma development: Challenges and opportunities for translational therapeutic advances.
Noncoding RNA Res. 2024 Nov 15;11:73-90. doi: 10.1016/j.ncrna.2024.11.005. eCollection 2025 Apr.
6
Targeted transcriptomic analysis of well-differentiated and dedifferentiated liposarcoma reveals multiple dysregulated pathways including glucose metabolism, TGF-β, and HIF-1 signaling.
Front Oncol. 2024 Nov 26;14:1456071. doi: 10.3389/fonc.2024.1456071. eCollection 2024.
7
Transmediastinal primary pulmonary liposarcoma: Case report and review of management strategies.
Rare Tumors. 2024 Aug 11;16:20363613241274230. doi: 10.1177/20363613241274230. eCollection 2024.
8
Myogenic dedifferentiation is associated with poor outcomes in retroperitoneal dedifferentiated liposarcomas.
Rare Tumors. 2021 Feb 26;13:2036361320986655. doi: 10.1177/2036361320986655. eCollection 2021.
本文引用的文献
1
Colon cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.
Cancer. 2017 Dec 15;123 Suppl 24(Suppl 24):5014-5036. doi: 10.1002/cncr.31076.
2
Impact of academic facility type and volume on post-surgical outcomes following diagnosis of glioblastoma.
J Clin Neurosci. 2018 Jan;47:103-110. doi: 10.1016/j.jocn.2017.10.087. Epub 2017 Nov 4.
3
Role of chemotherapy in dedifferentiated liposarcoma of the retroperitoneum: defining the benefit and challenges of the standard.
Sci Rep. 2017 Sep 19;7(1):11836. doi: 10.1038/s41598-017-12132-w.
4
Comparison of facility type outcomes for oral cavity cancer: Analysis of the national cancer database.
Laryngoscope. 2017 Nov;127(11):2551-2557. doi: 10.1002/lary.26632. Epub 2017 Jul 3.
5
Cancer survival disparities by health insurance status.
Cancer Med. 2013 Jun;2(3):403-11. doi: 10.1002/cam4.84. Epub 2013 May 8.
6
Update on liposarcoma: a review for cytopathologists.
Diagn Cytopathol. 2012 Dec;40(12):1122-31. doi: 10.1002/dc.21794. Epub 2011 Sep 19.
7
Well-differentiated and dedifferentiated liposarcomas.
Virchows Arch. 2010 Feb;456(2):167-79. doi: 10.1007/s00428-009-0815-x. Epub 2009 Aug 18.
8
Resectable well-differentiated versus dedifferentiated liposarcomas: two different diseases possibly requiring different treatment approaches.
Ann Surg Oncol. 2008 Jun;15(6):1585-93. doi: 10.1245/s10434-007-9805-x. Epub 2008 Apr 9.
9
Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis.
Lancet Oncol. 2008 Mar;9(3):222-31. doi: 10.1016/S1470-2045(08)70032-9. Epub 2008 Feb 20.
10
Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk.
Ann Surg. 2006 Sep;244(3):381-91. doi: 10.1097/01.sla.0000234795.98607.00.
Zotero 插件